Acute LSD effects on response inhibition neural networks

Recent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT2AR) is critically involved in the formation of visual hallucinations and cognitive impairments in lysergic acid diethylamide (LSD)-induced states and neuropsychiatric diseases. However, the interaction between...

Full description

Saved in:
Bibliographic Details
Published inPsychological medicine Vol. 48; no. 9; pp. 1464 - 1473
Main Authors Schmidt, A., Müller, F., Lenz, C., Dolder, P. C., Schmid, Y., Zanchi, D., Lang, U. E., Liechti, M. E., Borgwardt, S.
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.07.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT2AR) is critically involved in the formation of visual hallucinations and cognitive impairments in lysergic acid diethylamide (LSD)-induced states and neuropsychiatric diseases. However, the interaction between 5-HT2AR activation, cognitive impairments and visual hallucinations is still poorly understood. This study explored the effect of 5-HT2AR activation on response inhibition neural networks in healthy subjects by using LSD and further tested whether brain activation during response inhibition under LSD exposure was related to LSD-induced visual hallucinations. In a double-blind, randomized, placebo-controlled, cross-over study, LSD (100 µg) and placebo were administered to 18 healthy subjects. Response inhibition was assessed using a functional magnetic resonance imaging Go/No-Go task. LSD-induced visual hallucinations were measured using the 5 Dimensions of Altered States of Consciousness (5D-ASC) questionnaire. Relative to placebo, LSD administration impaired inhibitory performance and reduced brain activation in the right middle temporal gyrus, superior/middle/inferior frontal gyrus and anterior cingulate cortex and in the left superior frontal and postcentral gyrus and cerebellum. Parahippocampal activation during response inhibition was differently related to inhibitory performance after placebo and LSD administration. Finally, activation in the left superior frontal gyrus under LSD exposure was negatively related to LSD-induced cognitive impairments and visual imagery. Our findings show that 5-HT2AR activation by LSD leads to a hippocampal-prefrontal cortex-mediated breakdown of inhibitory processing, which might subsequently promote the formation of LSD-induced visual imageries. These findings help to better understand the neuropsychopharmacological mechanisms of visual hallucinations in LSD-induced states and neuropsychiatric disorders.
AbstractList Recent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT2AR) is critically involved in the formation of visual hallucinations and cognitive impairments in lysergic acid diethylamide (LSD)-induced states and neuropsychiatric diseases. However, the interaction between 5-HT2AR activation, cognitive impairments and visual hallucinations is still poorly understood. This study explored the effect of 5-HT2AR activation on response inhibition neural networks in healthy subjects by using LSD and further tested whether brain activation during response inhibition under LSD exposure was related to LSD-induced visual hallucinations.BACKGROUNDRecent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT2AR) is critically involved in the formation of visual hallucinations and cognitive impairments in lysergic acid diethylamide (LSD)-induced states and neuropsychiatric diseases. However, the interaction between 5-HT2AR activation, cognitive impairments and visual hallucinations is still poorly understood. This study explored the effect of 5-HT2AR activation on response inhibition neural networks in healthy subjects by using LSD and further tested whether brain activation during response inhibition under LSD exposure was related to LSD-induced visual hallucinations.In a double-blind, randomized, placebo-controlled, cross-over study, LSD (100 µg) and placebo were administered to 18 healthy subjects. Response inhibition was assessed using a functional magnetic resonance imaging Go/No-Go task. LSD-induced visual hallucinations were measured using the 5 Dimensions of Altered States of Consciousness (5D-ASC) questionnaire.METHODSIn a double-blind, randomized, placebo-controlled, cross-over study, LSD (100 µg) and placebo were administered to 18 healthy subjects. Response inhibition was assessed using a functional magnetic resonance imaging Go/No-Go task. LSD-induced visual hallucinations were measured using the 5 Dimensions of Altered States of Consciousness (5D-ASC) questionnaire.Relative to placebo, LSD administration impaired inhibitory performance and reduced brain activation in the right middle temporal gyrus, superior/middle/inferior frontal gyrus and anterior cingulate cortex and in the left superior frontal and postcentral gyrus and cerebellum. Parahippocampal activation during response inhibition was differently related to inhibitory performance after placebo and LSD administration. Finally, activation in the left superior frontal gyrus under LSD exposure was negatively related to LSD-induced cognitive impairments and visual imagery.RESULTSRelative to placebo, LSD administration impaired inhibitory performance and reduced brain activation in the right middle temporal gyrus, superior/middle/inferior frontal gyrus and anterior cingulate cortex and in the left superior frontal and postcentral gyrus and cerebellum. Parahippocampal activation during response inhibition was differently related to inhibitory performance after placebo and LSD administration. Finally, activation in the left superior frontal gyrus under LSD exposure was negatively related to LSD-induced cognitive impairments and visual imagery.Our findings show that 5-HT2AR activation by LSD leads to a hippocampal-prefrontal cortex-mediated breakdown of inhibitory processing, which might subsequently promote the formation of LSD-induced visual imageries. These findings help to better understand the neuropsychopharmacological mechanisms of visual hallucinations in LSD-induced states and neuropsychiatric disorders.CONCLUSIONOur findings show that 5-HT2AR activation by LSD leads to a hippocampal-prefrontal cortex-mediated breakdown of inhibitory processing, which might subsequently promote the formation of LSD-induced visual imageries. These findings help to better understand the neuropsychopharmacological mechanisms of visual hallucinations in LSD-induced states and neuropsychiatric disorders.
BackgroundRecent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT2AR) is critically involved in the formation of visual hallucinations and cognitive impairments in lysergic acid diethylamide (LSD)-induced states and neuropsychiatric diseases. However, the interaction between 5-HT2AR activation, cognitive impairments and visual hallucinations is still poorly understood. This study explored the effect of 5-HT2AR activation on response inhibition neural networks in healthy subjects by using LSD and further tested whether brain activation during response inhibition under LSD exposure was related to LSD-induced visual hallucinations.MethodsIn a double-blind, randomized, placebo-controlled, cross-over study, LSD (100 µg) and placebo were administered to 18 healthy subjects. Response inhibition was assessed using a functional magnetic resonance imaging Go/No-Go task. LSD-induced visual hallucinations were measured using the 5 Dimensions of Altered States of Consciousness (5D-ASC) questionnaire.ResultsRelative to placebo, LSD administration impaired inhibitory performance and reduced brain activation in the right middle temporal gyrus, superior/middle/inferior frontal gyrus and anterior cingulate cortex and in the left superior frontal and postcentral gyrus and cerebellum. Parahippocampal activation during response inhibition was differently related to inhibitory performance after placebo and LSD administration. Finally, activation in the left superior frontal gyrus under LSD exposure was negatively related to LSD-induced cognitive impairments and visual imagery.ConclusionOur findings show that 5-HT2AR activation by LSD leads to a hippocampal-prefrontal cortex-mediated breakdown of inhibitory processing, which might subsequently promote the formation of LSD-induced visual imageries. These findings help to better understand the neuropsychopharmacological mechanisms of visual hallucinations in LSD-induced states and neuropsychiatric disorders.
Recent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT2AR) is critically involved in the formation of visual hallucinations and cognitive impairments in lysergic acid diethylamide (LSD)-induced states and neuropsychiatric diseases. However, the interaction between 5-HT2AR activation, cognitive impairments and visual hallucinations is still poorly understood. This study explored the effect of 5-HT2AR activation on response inhibition neural networks in healthy subjects by using LSD and further tested whether brain activation during response inhibition under LSD exposure was related to LSD-induced visual hallucinations. In a double-blind, randomized, placebo-controlled, cross-over study, LSD (100 µg) and placebo were administered to 18 healthy subjects. Response inhibition was assessed using a functional magnetic resonance imaging Go/No-Go task. LSD-induced visual hallucinations were measured using the 5 Dimensions of Altered States of Consciousness (5D-ASC) questionnaire. Relative to placebo, LSD administration impaired inhibitory performance and reduced brain activation in the right middle temporal gyrus, superior/middle/inferior frontal gyrus and anterior cingulate cortex and in the left superior frontal and postcentral gyrus and cerebellum. Parahippocampal activation during response inhibition was differently related to inhibitory performance after placebo and LSD administration. Finally, activation in the left superior frontal gyrus under LSD exposure was negatively related to LSD-induced cognitive impairments and visual imagery. Our findings show that 5-HT2AR activation by LSD leads to a hippocampal-prefrontal cortex-mediated breakdown of inhibitory processing, which might subsequently promote the formation of LSD-induced visual imageries. These findings help to better understand the neuropsychopharmacological mechanisms of visual hallucinations in LSD-induced states and neuropsychiatric disorders.
Author Müller, F.
Liechti, M. E.
Schmid, Y.
Borgwardt, S.
Lang, U. E.
Zanchi, D.
Schmidt, A.
Dolder, P. C.
Lenz, C.
Author_xml – sequence: 1
  givenname: A.
  surname: Schmidt
  fullname: Schmidt, A.
  email: andre.schmidt@unibas.ch
  organization: 1Department of Psychiatry (UPK), University of Basel, Basel, Switzerland
– sequence: 2
  givenname: F.
  surname: Müller
  fullname: Müller, F.
  organization: 1Department of Psychiatry (UPK), University of Basel, Basel, Switzerland
– sequence: 3
  givenname: C.
  surname: Lenz
  fullname: Lenz, C.
  organization: 1Department of Psychiatry (UPK), University of Basel, Basel, Switzerland
– sequence: 4
  givenname: P. C.
  surname: Dolder
  fullname: Dolder, P. C.
  organization: 2Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University of Basel, University Hospital Basel, Basel, Switzerland
– sequence: 5
  givenname: Y.
  surname: Schmid
  fullname: Schmid, Y.
  organization: 2Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University of Basel, University Hospital Basel, Basel, Switzerland
– sequence: 6
  givenname: D.
  surname: Zanchi
  fullname: Zanchi, D.
  organization: 1Department of Psychiatry (UPK), University of Basel, Basel, Switzerland
– sequence: 7
  givenname: U. E.
  surname: Lang
  fullname: Lang, U. E.
  organization: 1Department of Psychiatry (UPK), University of Basel, Basel, Switzerland
– sequence: 8
  givenname: M. E.
  surname: Liechti
  fullname: Liechti, M. E.
  organization: 2Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University of Basel, University Hospital Basel, Basel, Switzerland
– sequence: 9
  givenname: S.
  surname: Borgwardt
  fullname: Borgwardt, S.
  organization: 1Department of Psychiatry (UPK), University of Basel, Basel, Switzerland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28967351$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtKxDAUhoOMOBd9ADdScOOmmpOmTbMcxisMuBhdlyRNNGMvY9Iivr0pMyoouvrhnO87HP4pGjVtoxE6BnwOGNjFCuMkIRwYMIxD0j00AZrxOOcsH6HJsI6H_RhNvV9jDAlQcoDGJOcZS1KYoHyu-k5Hy9VlpI3RqvNR20RO-03beB3Z5tlK29kwa3TvRBWie2vdiz9E-0ZUXh_tcoYer68eFrfx8v7mbjFfxormpIulojwTuJSpMZIZqikXhJUZ8JQzwVLIQKhcYUYhIUxjTo0koGRgSY6VSGbobHt349rXXvuuqK1XuqpEo9veF8BpyiAHkgX09Ae6bnvXhO8KglPCKKWYBOpkR_Wy1mWxcbYW7r347CQAsAWUa7132nwhgIuh9-JX78FhPxxlOzH01jlhq3_NZGeKWjpbPunvr_-2PgCsD5J1
CitedBy_id crossref_primary_10_1016_j_neubiorev_2022_104793
crossref_primary_10_1016_j_neubiorev_2023_105421
crossref_primary_10_1186_s12868_021_00680_x
crossref_primary_10_1080_15569527_2018_1423620
crossref_primary_10_3389_fnut_2021_609012
crossref_primary_10_9758_cpn_22_1035
crossref_primary_10_1002_cpt_2958
crossref_primary_10_1080_02791072_2022_2125467
crossref_primary_10_1016_j_celrep_2021_109714
crossref_primary_10_1016_j_neuropharm_2019_107856
crossref_primary_10_1093_brain_awab406
crossref_primary_10_1021_acschemneuro_9b00073
crossref_primary_10_1016_j_biopsych_2019_05_019
crossref_primary_10_1016_j_biopsych_2019_08_021
crossref_primary_10_1016_j_encep_2024_02_007
crossref_primary_10_1016_j_neubiorev_2022_104689
crossref_primary_10_1177_0269881120940937
crossref_primary_10_3389_fnbeh_2020_00111
crossref_primary_10_1021_acschemneuro_8b00043
crossref_primary_10_1080_13803395_2024_2363343
crossref_primary_10_3389_fnins_2022_832375
crossref_primary_10_1080_15569527_2020_1730883
crossref_primary_10_3389_fnrgo_2021_784576
crossref_primary_10_1017_S0033291722002963
crossref_primary_10_1038_s41598_023_44153_z
crossref_primary_10_3389_fphar_2021_739053
crossref_primary_10_1210_endocr_bqae083
crossref_primary_10_3390_brainsci14030248
crossref_primary_10_1038_s44159_024_00345_6
crossref_primary_10_3389_fnins_2018_00007
crossref_primary_10_1038_s41598_024_65391_9
crossref_primary_10_33361_RPQ_2022_v_10_n_24_505
crossref_primary_10_1097_ICU_0000000000000701
crossref_primary_10_1111_bcp_13918
crossref_primary_10_1007_s00213_018_4981_x
crossref_primary_10_1007_s00213_018_5055_9
crossref_primary_10_1002_hbm_23953
crossref_primary_10_1038_s42003_025_07576_0
crossref_primary_10_1556_2054_2019_014
Cites_doi 10.1037/0033-295X.108.3.624
10.1016/j.euroneuro.2012.10.018
10.1093/cercor/bhs256
10.1038/npp.2016.82
10.1001/archpsyc.61.2.119
10.1016/j.biopsych.2005.06.007
10.1016/j.neuron.2006.12.023
10.1016/j.neuropsychologia.2011.01.001
10.1136/jnnp.2007.116202
10.1093/schbul/sbs117
10.1097/00001756-199812010-00024
10.1016/S0920-9964(00)00173-0
10.1016/j.schres.2007.07.033
10.3389/fphar.2015.00225
10.3922/j.psns.2011.3.012
10.1093/brain/awu178
10.1002/hbm.20564
10.1093/ijnp/pyx037
10.1016/j.biopsych.2008.05.011
10.1007/s00216-014-8388-1
10.1017/S1461145713000722
10.1007/7854_2016_461
10.1016/j.bandc.2014.03.011
10.1016/j.schres.2013.12.005
10.1126/science.1105783
10.1016/j.cub.2016.12.030
10.1038/npp.2009.176
10.1007/s00213-016-4453-0
10.1136/jnnp.2009.179655
10.1515/tnsci-2016-0007
10.1002/mds.22258
10.1038/npp.2013.123
10.1016/j.biopsych.2014.11.015
10.1016/S0361-9230(01)00646-3
10.1016/j.neuroimage.2009.07.002
10.1093/cercor/bhm219
10.1016/j.tips.2008.06.006
10.1177/2045125314557797
10.3390/ijms17111953
10.1001/archpsyc.1963.01720120031005
10.1016/j.euroneuro.2014.11.018
10.1016/j.pneurobio.2013.06.005
10.1007/s40262-017-0513-9
10.1162/089892902317362029
10.1016/j.cortex.2007.11.007
10.1016/j.neuroimage.2006.04.189
10.1038/npp.2011.228
10.1007/s00213-003-1683-8
10.1017/S0033291714000920
10.1016/j.neuroimage.2011.02.070
10.1016/j.neuroimage.2013.12.058
10.1073/pnas.1518377113
10.1016/j.neuropsychologia.2007.07.015
10.1016/S1053-8119(03)00275-1
10.1017/S0033291715002901
10.1523/JNEUROSCI.3007-12.2013
10.1523/JNEUROSCI.1463-12.2012
10.1002/hbm.20237
10.1371/journal.pone.0012412
10.1093/brain/awl244
ContentType Journal Article
Copyright Copyright © Cambridge University Press 2017
Copyright_xml – notice: Copyright © Cambridge University Press 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
0-V
3V.
7QJ
7QP
7QR
7RV
7TK
7X7
7XB
88E
88G
8FD
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
ALSLI
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
HEHIP
K9.
KB0
M0S
M1P
M2M
M2O
M2S
MBDVC
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
POGQB
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PRQQA
PSYQQ
Q9U
7X8
DOI 10.1017/S0033291717002914
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Social Sciences Premium Collection【Remote access available】
ProQuest Central (Corporate)
Applied Social Sciences Index & Abstracts (ASSIA)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Social Science Premium Collection
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Sociology Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
Psychology Database (Proquest)
Research Library
Sociology Database
Research Library (Corporate)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest Sociology & Social Sciences Collection
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Social Sciences
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
Sociology & Social Sciences Collection
ProQuest Central China
Health Research Premium Collection
Health & Medical Research Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Sociology
ProQuest Medical Library (Alumni)
Social Science Premium Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Sociology Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Social Sciences Premium Collection
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Sociology & Social Sciences Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
Applied Social Sciences Index and Abstracts (ASSIA)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Sociology Collection
ProQuest One Social Sciences
ProQuest Central Basic
ProQuest Nursing & Allied Health Source
ProQuest Psychology Journals (Alumni)
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest One Psychology
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Psychological Medicine
A. Schmidt et al.
EISSN 1469-8978
EndPage 1473
ExternalDocumentID 28967351
10_1017_S0033291717002914
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Switzerland
GeographicLocations_xml – name: Switzerland
GroupedDBID ---
-1D
-1F
-2P
-2V
-E.
-~6
-~N
.FH
.GJ
.XZ
0-V
08P
09C
09E
0E1
0R~
123
29P
3V.
4.4
41~
53G
5RE
5VS
6~7
74X
74Y
7RV
7X7
7~V
88E
8FI
8FJ
8G5
8R4
8R5
9M5
AAAZR
AABES
AABWE
AACJH
AAEED
AAGFV
AAKTX
AAMNQ
AARAB
AASVR
AAUIS
AAUKB
AAWTL
AAYEP
ABBXD
ABBZL
ABGDZ
ABITZ
ABIVO
ABJNI
ABKKG
ABLJU
ABMYL
ABQTM
ABQWD
ABROB
ABTCQ
ABUWG
ABVFV
ABWCF
ABXAU
ABZCX
ABZUI
ACBMC
ACCHT
ACETC
ACGFO
ACGFS
ACHQT
ACIMK
ACIWK
ACPRK
ACQFJ
ACREK
ACUIJ
ACUYZ
ACWGA
ACYZP
ACZBM
ACZUX
ADAZD
ADBBV
ADDNB
ADFEC
ADFRT
ADGEJ
ADKIL
ADOCW
ADOVH
ADOVT
ADVJH
AEBAK
AEBPU
AEHGV
AEMTW
AENCP
AENEX
AENGE
AEPLO
AEYHU
AEYYC
AFFNX
AFFUJ
AFKQG
AFKRA
AFKSM
AFLOS
AFLVW
AFUTZ
AGABE
AGJUD
AGLWM
AGOOT
AHIPN
AHLTW
AHMBA
AHQXX
AHRGI
AIGNW
AIHIV
AIOIP
AISIE
AJ7
AJCYY
AJPFC
AJQAS
AKZCZ
ALMA_UNASSIGNED_HOLDINGS
ALSLI
ALVPG
ANPSP
AQJOH
ARABE
ARALO
ARZZG
ASOEW
ATUCA
AUXHV
AYIQA
AZGZS
AZQEC
BBLKV
BCGOX
BENPR
BESQT
BGHMG
BJBOZ
BKEYQ
BLZWO
BMAJL
BPHCQ
BQFHP
BRIRG
BVXVI
C0O
C45
CAG
CBIIA
CCPQU
CCQAD
CCUQV
CDIZJ
CFAFE
CFBFF
CGQII
CHEAL
CJCSC
COF
CS3
DC4
DOHLZ
DU5
DWQXO
EBS
EGQIC
EJD
EX3
F5P
FA8
FYUFA
GNUQQ
GUQSH
HEHIP
HG-
HMCUK
HST
HZ~
H~9
I.6
I.7
I.9
IH6
IOEEP
IOO
IS6
I~P
J36
J38
J3A
J5H
JHPGK
JQKCU
JVRFK
KAFGG
KC5
KCGVB
KFECR
L7B
L98
LHUNA
LW7
M-V
M1P
M2M
M2O
M2S
M7~
M8.
N4W
NAPCQ
NEJ
NIKVX
NMFBF
NZEOI
O9-
OMB
OMC
OMH
OVD
OYBOY
P2P
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RCA
RIG
ROL
RR0
S6-
S6U
SAAAG
SY4
T9M
TEORI
UAP
UCJ
UKHRP
UT1
UU6
VVN
WFFJZ
WH7
WOW
WQ3
WXU
WXY
WYP
YOC
YZZ
ZA5
ZCA
ZDLDU
ZGI
ZJOSE
ZMEZD
ZXP
ZYDXJ
~V1
AAKNA
AATMM
AAYXX
ABHFL
ABVKB
ABVZP
ABXHF
ACDLN
ACEJA
ACOZI
ACRPL
ADNMO
ADPDF
AEMFK
AFZFC
AGQPQ
AKMAY
ALIPV
ANOYL
CITATION
IPYYG
PHGZM
PHGZT
AAFWJ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
POGQB
PPXIY
PRQQA
7QJ
7QP
7QR
7TK
7XB
8FD
8FK
FR3
K9.
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c482t-bc496a0db5ffb7f4e49a27d619597a75161ac8c0741327e094fb21cbb7f280ca3
IEDL.DBID 7X7
ISSN 0033-2917
1469-8978
IngestDate Mon Jul 21 11:59:33 EDT 2025
Fri Jul 25 19:59:26 EDT 2025
Mon Jul 21 05:48:02 EDT 2025
Tue Jul 01 04:15:56 EDT 2025
Thu Apr 24 23:10:44 EDT 2025
Wed Mar 13 05:37:09 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords fMRI
visual hallucinations
LSD
Cognitive control
Language English
License https://www.cambridge.org/core/terms
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c482t-bc496a0db5ffb7f4e49a27d619597a75161ac8c0741327e094fb21cbb7f280ca3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://edoc.unibas.ch/63377/1/20171204150352_5a2555c85b181.pdf
PMID 28967351
PQID 2052744402
PQPubID 35753
PageCount 10
ParticipantIDs proquest_miscellaneous_1945718126
proquest_journals_2052744402
pubmed_primary_28967351
crossref_primary_10_1017_S0033291717002914
crossref_citationtrail_10_1017_S0033291717002914
cambridge_journals_10_1017_S0033291717002914
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-07-01
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Cambridge, UK
PublicationPlace_xml – name: Cambridge, UK
– name: England
– name: Cambridge
PublicationTitle Psychological medicine
PublicationTitleAlternate Psychol. Med
PublicationYear 2018
Publisher Cambridge University Press
Publisher_xml – name: Cambridge University Press
References Bhattacharyya 2015; 25
Daly 2014; 137
Schmid 2015; 78
Schmitz 2006; 59
Godsil 2013; 23
Štrac, Pivac, Mück-Šeler 2016; 7
Geyer, Vollenweider 2008; 29
González-Maeso, Sealfon 2009; 32
Steeds, Carhart-Harris, Stone 2015; 5
Barnes, Boubert 2008; 79
Tully 2014; 152
Ramírez-Ruiz 2008; 23
Dolder 2017
du Boisgueheneuc 2006; 129
Gama 2014; 87
Cieslik 2013; 23
Roth, Hanizavareh, Blum 2004; 174
Chudasama, Doobay, Liu 2012; 32
Sigurdsson, Duvarci 2015; 9
Dolder, Liechti, Rentsch 2015a; 407
Wapner, Krus 1960; 2
Johnston 2007; 53
Kometer 2013; 33
Simmonds, Pekar, Mostofsky 2008; 46
Ibarretxe-Bilbao 2010; 81
Woo, Krishnan, Wager 2014; 91
Vollenweider, Geyer 2001; 56
Dolder 2015b
Roth 2009; 48
Kumari 2008; 44
Bhattacharyya 2014; 44
Zhang, Stackman 2015; 6
Swick, Ashley, Turken 2011; 56
Bari, Robbins 2013; 108
Carhart-Harris 2016a; 46
De Gregorio 2016; 17
Botvinick 2001; 108
Carhart-Harris 2016b; 113
Dolder 2016; 41
Hester 2008; 18
Halberstadt, Geyer 2013; 16
Arce 2006; 32
Borgwardt 2008; 64
Ford 2004; 61
Rubia 2001; 52
Meltzer 2010; 35
Schmidt 2017; 20
Vollenweider 1998; 9
Rubia 2003; 20
Braet 2011; 49
Kaladjian 2007; 97
Rubia 2006; 27
Brown, Braver 2005; 307
Grossi 2011; 4
Quednow 2011; 37
Krus 1963; 8
Lawrence 2009; 30
Kometer, Vollenweider 2016
Liechti, Dolder, Schmid 2016; 234
Carhart-Harris 2013; 39
Preller 2017; 27
Corbetta, Kincade, Shulman 2002; 14
Studerus, Gamma, Vollenweider 2010; 5
Schmidt 2013; 38
Dolder (S0033291717002914_ref20) 2015b
S0033291717002914_ref60
S0033291717002914_ref61
S0033291717002914_ref11
S0033291717002914_ref55
S0033291717002914_ref12
S0033291717002914_ref13
S0033291717002914_ref57
S0033291717002914_ref14
S0033291717002914_ref51
S0033291717002914_ref52
S0033291717002914_ref53
S0033291717002914_ref10
S0033291717002914_ref19
S0033291717002914_ref59
S0033291717002914_ref15
S0033291717002914_ref16
S0033291717002914_ref17
S0033291717002914_ref18
S0033291717002914_ref50
S0033291717002914_ref44
S0033291717002914_ref45
S0033291717002914_ref46
S0033291717002914_ref47
S0033291717002914_ref40
S0033291717002914_ref41
S0033291717002914_ref42
S0033291717002914_ref43
González-Maeso (S0033291717002914_ref28) 2009; 32
S0033291717002914_ref48
S0033291717002914_ref49
Wapner (S0033291717002914_ref64) 1960; 2
S0033291717002914_ref33
S0033291717002914_ref34
S0033291717002914_ref35
S0033291717002914_ref36
S0033291717002914_ref30
S0033291717002914_ref31
S0033291717002914_ref32
S0033291717002914_ref37
S0033291717002914_ref38
S0033291717002914_ref39
S0033291717002914_ref8
S0033291717002914_ref9
Štrac (S0033291717002914_ref58) 2016; 7
S0033291717002914_ref4
S0033291717002914_ref5
S0033291717002914_ref6
S0033291717002914_ref7
Sigurdsson (S0033291717002914_ref54) 2015; 9
S0033291717002914_ref66
S0033291717002914_ref22
S0033291717002914_ref23
S0033291717002914_ref24
S0033291717002914_ref25
S0033291717002914_ref62
S0033291717002914_ref63
S0033291717002914_ref65
S0033291717002914_ref21
S0033291717002914_ref1
S0033291717002914_ref3
S0033291717002914_ref26
S0033291717002914_ref27
S0033291717002914_ref29
References_xml – volume: 38
  start-page: 2231
  year: 2013
  end-page: 2239
  article-title: Inferior frontal cortex modulation with an acute dose of heroin during cognitive control
  publication-title: Neuropsychopharmacology
– volume: 25
  start-page: 26
  year: 2015
  end-page: 37
  article-title: Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis
  publication-title: European Neuropsychopharmacology
– volume: 49
  start-page: 1641
  year: 2011
  end-page: 1650
  article-title: fMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHD
  publication-title: Neuropsychologia
– volume: 33
  start-page: 10544
  year: 2013
  end-page: 10551
  article-title: Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations
  publication-title: Journal of Neuroscience
– volume: 20
  start-page: 351
  year: 2003
  end-page: 358
  article-title: Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection
  publication-title: NeuroImage
– volume: 108
  start-page: 624
  year: 2001
  end-page: 652
  article-title: Conflict monitoring and cognitive control
  publication-title: Psychological Review
– year: 2016
  article-title: Serotonergic hallucinogen-induced visual perceptual alterations
  publication-title: Current Topics in Behavioral Neurosciences
– volume: 44
  start-page: 3315
  year: 2014
  end-page: 3328
  article-title: Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control
  publication-title: Psychological Medicine
– volume: 17
  year: 2016
  article-title: d-Lysergic acid diethylamide (LSD) as a model of psychosis: mechanism of action and pharmacology
  publication-title: International Journal of Molecular Sciences
– volume: 23
  start-page: 2335
  year: 2008
  end-page: 2343
  article-title: Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study
  publication-title: Movement Disorders
– year: 2017
  article-title: Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects
  publication-title: Clinical Pharmacokinetics
– volume: 39
  start-page: 1343
  year: 2013
  end-page: 1351
  article-title: Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis
  publication-title: Schizophrenia Bulletin
– volume: 113
  start-page: 4853
  year: 2016b
  end-page: 4858
  article-title: Neural correlates of the LSD experience revealed by multimodal neuroimaging
  publication-title: Proceedings of the National Academy of Sciences of the USA
– volume: 46
  start-page: 1379
  year: 2016a
  end-page: 1390
  article-title: The paradoxical psychological effects of lysergic acid diethylamide (LSD)
  publication-title: Psychological Medicine
– volume: 2
  start-page: 76
  year: 1960
  end-page: 81
  article-title: Effects of lysergic acid diethylamide, and differences between normals and schizophrenics on the Stroop Color-Word Test
  publication-title: Journal of Neuropsychiatry
– volume: 14
  start-page: 508
  year: 2002
  end-page: 523
  article-title: Neural systems for visual orienting and their relationships to spatial working memory
  publication-title: Journal of Cognitive Neuroscience
– volume: 129
  start-page: 3315
  year: 2006
  end-page: 3328
  article-title: Functions of the left superior frontal gyrus in humans: a lesion study
  publication-title: Brain
– volume: 29
  start-page: 445
  year: 2008
  end-page: 453
  article-title: Serotonin research: contributions to understanding psychoses
  publication-title: Trends in Pharmacological Sciences
– volume: 46
  start-page: 224
  year: 2008
  end-page: 232
  article-title: Meta-analysis of Go/No-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent
  publication-title: Neuropsychologia
– volume: 78
  start-page: 544
  year: 2015
  end-page: 553
  article-title: Acute effects of lysergic acid diethylamide in healthy subjects
  publication-title: Biological Psychiatry
– volume: 407
  start-page: 1577
  year: 2015a
  end-page: 1584
  article-title: Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases
  publication-title: Analytical and Bioanalytical Chemistry
– volume: 27
  start-page: 451
  year: 2017
  end-page: 457
  article-title: The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation
  publication-title: Current Biology
– volume: 53
  start-page: 453
  year: 2007
  end-page: 462
  article-title: Top-down control-signal dynamics in anterior cingulate and prefrontal cortex neurons following task switching
  publication-title: Neuron
– volume: 27
  start-page: 973
  year: 2006
  end-page: 993
  article-title: Progressive increase of frontostriatal brain activation from childhood to adulthood during event-related tasks of cognitive control
  publication-title: Human Brain Mapping
– volume: 18
  start-page: 1933
  year: 2008
  end-page: 1940
  article-title: Human medial frontal cortex activity predicts learning from errors
  publication-title: Cerebral Cortex
– volume: 30
  start-page: 1038
  year: 2009
  end-page: 1050
  article-title: The neural basis of response inhibition and attention allocation as mediated by gestational age
  publication-title: Human Brain Mapping
– volume: 5
  start-page: 43
  year: 2015
  end-page: 58
  article-title: Drug models of schizophrenia
  publication-title: Therapeutic Advances in Psychopharmacology
– volume: 37
  start-page: 630
  year: 2011
  end-page: 640
  article-title: Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers
  publication-title: Neuropsychopharmacology
– volume: 56
  start-page: 1655
  year: 2011
  end-page: 1665
  article-title: Are the neural correlates of stopping and not going identical? Quantitative meta-analysis of two response inhibition tasks
  publication-title: NeuroImage
– volume: 52
  start-page: 47
  year: 2001
  end-page: 55
  article-title: An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function
  publication-title: Schizophrenia Research
– volume: 48
  start-page: 601
  year: 2009
  end-page: 608
  article-title: Similar and dissociable mechanisms for attention to internal versus external information
  publication-title: NeuroImage
– volume: 4
  start-page: 385
  year: 2011
  end-page: 389
  article-title: Do frontal dysfunctions play a role in visual hallucinations in Alzheimer's disease as in Parkinson's disease? A comparative study
  publication-title: Psychology & Neuroscience
– volume: 59
  start-page: 7
  year: 2006
  end-page: 16
  article-title: Neural correlates of executive function in autistic spectrum disorders
  publication-title: Biological Psychiatry
– volume: 6
  start-page: 225
  year: 2015
  article-title: The role of serotonin 5-HT2A receptors in memory and cognition
  publication-title: Frontiers in Pharmacology
– volume: 174
  start-page: 17
  year: 2004
  end-page: 24
  article-title: Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders
  publication-title: Psychopharmacology
– volume: 91
  start-page: 412
  year: 2014
  end-page: 419
  article-title: Cluster-extent based thresholding in fMRI analyses: pitfalls and recommendations
  publication-title: NeuroImage
– volume: 56
  start-page: 495
  year: 2001
  end-page: 507
  article-title: A systems model of altered consciousness: integrating natural and drug-induced psychoses
  publication-title: Brain Research Bulletin
– volume: 234
  start-page: 1499
  year: 2016
  end-page: 1510
  article-title: Alterations of consciousness and mystical-type experiences after acute LSD in humans
  publication-title: Psychopharmacology
– volume: 32
  start-page: 225
  year: 2009
  end-page: 232
  article-title: Psychedelics and schizophrenia
  publication-title: Trends in Pharmacological Sciences
– volume: 23
  start-page: 1165
  year: 2013
  end-page: 1181
  article-title: The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?
  publication-title: European Neuropsychopharmacolog
– volume: 108
  start-page: 44
  year: 2013
  end-page: 79
  article-title: Inhibition and impulsivity: behavioral and neural basis of response control
  publication-title: Progress in Neurobiology
– volume: 64
  start-page: 966
  year: 2008
  end-page: 973
  article-title: Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition
  publication-title: Biological Psychiatry
– volume: 137
  start-page: 2600
  year: 2014
  end-page: 2610
  article-title: Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion
  publication-title: Brain
– volume: 44
  start-page: 1206
  year: 2008
  end-page: 1214
  article-title: Cortical grey matter volume and sensorimotor gating in schizophrenia
  publication-title: Cortex
– volume: 9
  start-page: 3897
  year: 1998
  end-page: 3902
  article-title: Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
  publication-title: Neuroreport
– volume: 32
  start-page: 10915
  year: 2012
  end-page: 10924
  article-title: Hippocampal-prefrontal cortical circuit mediates inhibitory response control in the rat
  publication-title: Journal of Neuroscience
– year: 2015b
  article-title: Pharmacokinetics and concentration-effect relationship of oral LSD in humans
  publication-title: International Journal of Neuropsychopharmacology
– volume: 32
  start-page: 704
  year: 2006
  end-page: 713
  article-title: Individuals with schizophrenia present hypo- and hyperactivation during implicit cueing in an inhibitory task
  publication-title: NeuroImage
– volume: 61
  start-page: 119
  year: 2004
  end-page: 129
  article-title: Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging
  publication-title: Archives of General Psychiatry
– volume: 35
  start-page: 881
  year: 2010
  end-page: 892
  article-title: Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of Parkinson's disease psychosis
  publication-title: Neuropsychopharmacology
– volume: 23
  start-page: 2677
  year: 2013
  end-page: 2689
  article-title: Is there ‘one’ DLPFC in cognitive action control? Evidence for heterogeneity from co-activation-based parcellation
  publication-title: Cerebral Cortex
– volume: 307
  start-page: 1118
  year: 2005
  end-page: 1121
  article-title: Learned predictions of error likelihood in the anterior cingulate cortex
  publication-title: Science
– volume: 87
  start-page: 97
  year: 2014
  end-page: 103
  article-title: Structural brain abnormalities in patients with Parkinson's disease with visual hallucinations: a comparative voxel-based analysis
  publication-title: Brain and Cognition
– volume: 20
  start-page: 712
  year: 2017
  end-page: 720
  article-title: Comparative effects of methylphenidate, modafinil and MDMA on response inhibition neural networks in healthy subjects
  publication-title: International Journal of Neuropsychopharmacology
– volume: 5
  year: 2010
  article-title: Psychometric evaluation of the altered states of consciousness rating scale (OAV)
  publication-title: PLoS ONE
– volume: 9
  start-page: 190
  year: 2015
  article-title: Hippocampal-prefrontal interactions in cognition, behavior and psychiatric disease
  publication-title: Frontiers in Systems Neuroscience
– volume: 16
  start-page: 2165
  year: 2013
  end-page: 2180
  article-title: Serotonergic hallucinogens as translational models relevant to schizophrenia
  publication-title: International Journal of Neuropsychopharmacology
– volume: 8
  start-page: 557
  year: 1963
  end-page: 563
  article-title: Differential behavioral responsivity to LSD-25, study in normal and schizophrenic adults
  publication-title: Archives of General Psychiatry
– volume: 79
  start-page: 190
  year: 2008
  end-page: 192
  article-title: Executive functions are impaired in patients with Parkinson's disease with visual hallucinations
  publication-title: Journal of Neurology, Neurosurgery and Psychiatry
– volume: 97
  start-page: 184
  year: 2007
  end-page: 193
  article-title: Blunted activation in right ventrolateral prefrontal cortex during motor response inhibition in schizophrenia
  publication-title: Schizophrenia Research
– volume: 41
  start-page: 2638
  year: 2016
  end-page: 2646
  article-title: LSD acutely impairs fear recognition and enhances emotional empathy and sociality
  publication-title: Neuropsychopharmacology
– volume: 7
  start-page: 35
  year: 2016
  end-page: 49
  article-title: The serotonergic system and cognitive function
  publication-title: Translational Neuroscience
– volume: 152
  start-page: 358
  year: 2014
  end-page: 364
  article-title: Impaired cognitive control mediates the relationship between cortical thickness of the superior frontal gyrus and role functioning in schizophrenia
  publication-title: Schizophrenia Research
– volume: 81
  start-page: 650
  year: 2010
  end-page: 657
  article-title: Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations
  publication-title: Journal of Neurology, Neurosurgery and Psychiatry
– ident: S0033291717002914_ref8
  doi: 10.1037/0033-295X.108.3.624
– ident: S0033291717002914_ref27
  doi: 10.1016/j.euroneuro.2012.10.018
– ident: S0033291717002914_ref15
  doi: 10.1093/cercor/bhs256
– year: 2015b
  ident: S0033291717002914_ref20
  article-title: Pharmacokinetics and concentration-effect relationship of oral LSD in humans
  publication-title: International Journal of Neuropsychopharmacology
– ident: S0033291717002914_ref21
  doi: 10.1038/npp.2016.82
– volume: 9
  start-page: 190
  year: 2015
  ident: S0033291717002914_ref54
  article-title: Hippocampal-prefrontal interactions in cognition, behavior and psychiatric disease
  publication-title: Frontiers in Systems Neuroscience
– ident: S0033291717002914_ref24
  doi: 10.1001/archpsyc.61.2.119
– ident: S0033291717002914_ref53
  doi: 10.1016/j.biopsych.2005.06.007
– ident: S0033291717002914_ref33
  doi: 10.1016/j.neuron.2006.12.023
– ident: S0033291717002914_ref9
  doi: 10.1016/j.neuropsychologia.2011.01.001
– ident: S0033291717002914_ref4
  doi: 10.1136/jnnp.2007.116202
– ident: S0033291717002914_ref12
  doi: 10.1093/schbul/sbs117
– ident: S0033291717002914_ref62
  doi: 10.1097/00001756-199812010-00024
– ident: S0033291717002914_ref47
  doi: 10.1016/S0920-9964(00)00173-0
– ident: S0033291717002914_ref34
  doi: 10.1016/j.schres.2007.07.033
– ident: S0033291717002914_ref66
  doi: 10.3389/fphar.2015.00225
– volume: 32
  start-page: 225
  year: 2009
  ident: S0033291717002914_ref28
  article-title: Psychedelics and schizophrenia
  publication-title: Trends in Pharmacological Sciences
– ident: S0033291717002914_ref29
  doi: 10.3922/j.psns.2011.3.012
– ident: S0033291717002914_ref17
  doi: 10.1093/brain/awu178
– ident: S0033291717002914_ref39
  doi: 10.1002/hbm.20564
– ident: S0033291717002914_ref51
  doi: 10.1093/ijnp/pyx037
– ident: S0033291717002914_ref7
  doi: 10.1016/j.biopsych.2008.05.011
– ident: S0033291717002914_ref19
  doi: 10.1007/s00216-014-8388-1
– ident: S0033291717002914_ref30
  doi: 10.1017/S1461145713000722
– ident: S0033291717002914_ref36
  doi: 10.1007/7854_2016_461
– ident: S0033291717002914_ref25
  doi: 10.1016/j.bandc.2014.03.011
– ident: S0033291717002914_ref61
  doi: 10.1016/j.schres.2013.12.005
– ident: S0033291717002914_ref10
  doi: 10.1126/science.1105783
– ident: S0033291717002914_ref42
  doi: 10.1016/j.cub.2016.12.030
– ident: S0033291717002914_ref41
  doi: 10.1038/npp.2009.176
– ident: S0033291717002914_ref40
  doi: 10.1007/s00213-016-4453-0
– ident: S0033291717002914_ref32
  doi: 10.1136/jnnp.2009.179655
– volume: 7
  start-page: 35
  year: 2016
  ident: S0033291717002914_ref58
  article-title: The serotonergic system and cognitive function
  publication-title: Translational Neuroscience
  doi: 10.1515/tnsci-2016-0007
– ident: S0033291717002914_ref44
  doi: 10.1002/mds.22258
– volume: 2
  start-page: 76
  year: 1960
  ident: S0033291717002914_ref64
  article-title: Effects of lysergic acid diethylamide, and differences between normals and schizophrenics on the Stroop Color-Word Test
  publication-title: Journal of Neuropsychiatry
– ident: S0033291717002914_ref52
  doi: 10.1038/npp.2013.123
– ident: S0033291717002914_ref50
  doi: 10.1016/j.biopsych.2014.11.015
– ident: S0033291717002914_ref63
  doi: 10.1016/S0361-9230(01)00646-3
– ident: S0033291717002914_ref46
  doi: 10.1016/j.neuroimage.2009.07.002
– ident: S0033291717002914_ref31
  doi: 10.1093/cercor/bhm219
– ident: S0033291717002914_ref26
  doi: 10.1016/j.tips.2008.06.006
– ident: S0033291717002914_ref57
  doi: 10.1177/2045125314557797
– ident: S0033291717002914_ref18
  doi: 10.3390/ijms17111953
– ident: S0033291717002914_ref37
  doi: 10.1001/archpsyc.1963.01720120031005
– ident: S0033291717002914_ref5
  doi: 10.1016/j.euroneuro.2014.11.018
– ident: S0033291717002914_ref3
  doi: 10.1016/j.pneurobio.2013.06.005
– ident: S0033291717002914_ref22
  doi: 10.1007/s40262-017-0513-9
– ident: S0033291717002914_ref16
  doi: 10.1162/089892902317362029
– ident: S0033291717002914_ref38
  doi: 10.1016/j.cortex.2007.11.007
– ident: S0033291717002914_ref1
  doi: 10.1016/j.neuroimage.2006.04.189
– ident: S0033291717002914_ref43
  doi: 10.1038/npp.2011.228
– ident: S0033291717002914_ref45
  doi: 10.1007/s00213-003-1683-8
– ident: S0033291717002914_ref6
  doi: 10.1017/S0033291714000920
– ident: S0033291717002914_ref60
  doi: 10.1016/j.neuroimage.2011.02.070
– ident: S0033291717002914_ref65
  doi: 10.1016/j.neuroimage.2013.12.058
– ident: S0033291717002914_ref13
  doi: 10.1073/pnas.1518377113
– ident: S0033291717002914_ref55
  doi: 10.1016/j.neuropsychologia.2007.07.015
– ident: S0033291717002914_ref48
  doi: 10.1016/S1053-8119(03)00275-1
– ident: S0033291717002914_ref11
  doi: 10.1017/S0033291715002901
– ident: S0033291717002914_ref35
  doi: 10.1523/JNEUROSCI.3007-12.2013
– ident: S0033291717002914_ref14
  doi: 10.1523/JNEUROSCI.1463-12.2012
– ident: S0033291717002914_ref49
  doi: 10.1002/hbm.20237
– ident: S0033291717002914_ref59
  doi: 10.1371/journal.pone.0012412
– ident: S0033291717002914_ref23
  doi: 10.1093/brain/awl244
SSID ssj0013142
Score 2.4470396
Snippet Recent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT2AR) is critically involved in the formation of visual hallucinations...
BackgroundRecent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT2AR) is critically involved in the formation of visual...
SourceID proquest
pubmed
crossref
cambridge
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1464
SubjectTerms Adult
Altered states
Alzheimer's disease
Behavior disorders
Brain
Brain Mapping
Brain research
Cerebellum
Cognition & reasoning
Cognitive ability
Cognitive impairment
Consciousness
Cortex
Cortex (cingulate)
Cross-Over Studies
Double-Blind Method
Family medical history
Female
Frontal gyrus
Functional magnetic resonance imaging
Go/no-go discrimination learning
Hallucinations
Hallucinations - chemically induced
Hallucinations - physiopathology
Hallucinogens - administration & dosage
Health care
Healthy Volunteers
Hippocampus
Hippocampus - drug effects
Hippocampus - physiopathology
Humans
Induced
LSD
Lysergic acid diethylamide
Lysergic Acid Diethylamide - pharmacology
Lysergide
Magnetic Resonance Imaging
Male
Mental disorders
Mental task performance
Middle Aged
Narcotics
Neural networks
Neuroimaging
Neuropsychological Tests
Neurosciences
NMR
Nuclear magnetic resonance
Original Articles
Parahippocampal gyrus
Postcentral gyrus
Prefrontal cortex
Prefrontal Cortex - drug effects
Prefrontal Cortex - physiopathology
Psychiatry
Psychosis
Questionnaires
Response inhibition
Schizophrenia
Serotonin
Serotonin receptors
Serotonin S2 receptors
Switzerland
Temporal gyrus
Temporal lobe
Visual cortex
Visual hallucinations
Visual imagery
Visual perception
Visual system
Title Acute LSD effects on response inhibition neural networks
URI https://www.cambridge.org/core/product/identifier/S0033291717002914/type/journal_article
https://www.ncbi.nlm.nih.gov/pubmed/28967351
https://www.proquest.com/docview/2052744402
https://www.proquest.com/docview/1945718126
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA-6gfgifjudo4JPYqEfSZM-ydSNITrED9hbSdIUB9LOrfv_vTRpp4h7KqRJmt5d07vcj98hdEmklwVpFLo-uA8uFiFxBQuFSyT2VZpJzSql0RbjaPSOHyZkYg_cFhZWWe-J1UadFlKfkUOQTjSZHYQ7N7MvV1eN0tlVW0JjE7U1dZm2ajqhqyyCjw1beFWvzKd1VrOijIZG3ab56eCKf3Ir_P5H_eN4Vj-g4S7asZ6j0zeq3kMbKt9HW082N36AWF8uS-U8vt47FqThFLkzNxhY5Uzzj6mo8FmO5rCEmXKDAF8covfh4O1u5Nq6CK7ELChdIXEccS8VJMsEzbDCMQ9oGmkJUE4JOHFcMqmdhTCgCgK4TAS-FNA3YJ7k4RFq5UWuTpDDIp6BRkKWSoYZjI8xJpynYSxjSUTUQdeNVBJr3YvEIMNo8keIHeTVgkuk5RjXpS4-1w25aobMDMHGus7dWhur1awso4MumtvwlejUB89VsYQVx5hQ7czAGx0bLTZPg5AzoiHxT9dPfoa2wVliBqrbRa1yvlTn4JCUoldZXQ-1bwfj55dvRYLX3g
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LS8QwEB58gHoR367PCHoRC30kTXoQER-sunpRYW81SVMUpKvuLuKf8jc6adpdRdybp0KapOlkksx0vn4DsMu0n4dZHHkBmg8eVRHzlIiUxzQNTJZryypl0RY3cfOeXrZZeww-639hLKyy3hPLjTrraPuNHJ10Zsns0N05enn1bNYoG12tU2g4tbgyH-_osnUPL05xfvfC8Pzs7qTpVVkFPE1F2POUpkks_UyxPFc8p4YmMuRZbFlWuOQMTSCphbZHbRRyg-5PrsJAK6wbCl_LCPsdh0k8eH3r7PE2H0YtAurYycv8aAGvo6glRTUW2jLLh4dX-p3L4eeZ-IehWx5453MwW1mq5Nip1jyMmWIBpq6rWPwiiGPd7xnSuj0lFSiEdAry5jC3hjwVj0-qxIMRy5mJPRUOcd5dgvt_kdgyTBSdwqwCEbHMUQMikWlBBbZPKGVSZlGiE81U3ICDgVTSajV1U4dE4-kvITbArwWX6orT3KbWeB7VZH_Q5MUReoyqvFHPxnA0Q01swM7gNq5KG2qRhen0ccQJZdwaT_hGK24WB09DFzfmEQvWRne-DdPNu-tW2rq4uVqHGTTUhIMJb8BE761vNtEY6qmtUgMJPPy3yn8BNLwTUg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9swED-VVkK8TGx8FdhmJHhBRDSJHTsPCHVrKz5KhYBKvAXbcQTSlAJtNe1f21-3c5y0myb6xlMkx3ac89m-y_3yO4B9pltZkEah56P54FEVMk-JUHlMU9-kmbasUhZtMYjOhvTint3X4Hf1L4yFVVZ7YrFRpyNtv5Gjk84smR26O8dZCYu47vROn188m0HKRlqrdBpORS7Nr5_ovo1Pzjs41wdB0OvefT_zygwDnqYimHhK0ziSrVSxLFM8o4bGMuBpZBlXuOQMzSGphbbHbhhwg65QpgJfK6wbiJaWIfa7BA1uvaI6NL51B9c38xiGTx1XeZEtzedVTLUgrMZCW2bZ8fBK_2Z2-PeEfMPsLY6_3ip8KO1W0naK9hFqJv8Ey1dlZH4NRFtPJ4b0bzukhIiQUU5eHQLXkKf88UkV6DBiGTSxp9zhz8frMHwXmW1APR_lZguIiGSG-hCKVAsqsH1MKZMyDWMda6aiJhzNpJKUa2ucOFwaT_4TYhNaleASXTKc20QbPxY1OZw1eXb0Hosq71azMR_NXC-bsDe7jWvUBl5kbkZTHHFMGbemFL7RppvF2dPQ4Y14yPztxZ1_hWVU96R_PrjcgRW02oTDDO9CffI6NZ_RMpqoL6UKEnh4b63_AyEbGO0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acute+LSD+effects+on+response+inhibition+neural+networks&rft.jtitle=Psychological+medicine&rft.au=Schmidt%2C+A.&rft.au=M%C3%BCller%2C+F.&rft.au=Lenz%2C+C.&rft.au=Dolder%2C+P.+C.&rft.date=2018-07-01&rft.issn=0033-2917&rft.eissn=1469-8978&rft.volume=48&rft.issue=9&rft.spage=1464&rft.epage=1473&rft_id=info:doi/10.1017%2FS0033291717002914&rft.externalDBID=n%2Fa&rft.externalDocID=10_1017_S0033291717002914
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-2917&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-2917&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-2917&client=summon